Richard S Levy - Net Worth and Insider Trading

Richard S Levy Net Worth

The estimated net worth of Richard S Levy is at least $3 Million dollars as of 2024-04-25. Richard S Levy is the Director of Madrigal Pharmaceuticals Inc and owns about 10,298 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $2 Million. Richard S Levy is the EVP, Chief Drug Dev Officer of Incyte Corp and owns about 16,926 shares of Incyte Corp (INCY) stock worth over $875,751. Richard S Levy is also the Director of Kodiak Sciences Inc and owns about 1,000 shares of Kodiak Sciences Inc (KOD) stock worth over $3,380. Details can be seen in Richard S Levy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard S Levy has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).

Transaction Summary of Richard S Levy

Richard S Levy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard S Levy owns 7 companies in total, including Kodiak Sciences Inc (KOD) , Kiniksa Pharmaceuticals Ltd (KNSA) , and Madrigal Pharmaceuticals Inc (MDGL) among others .

Click here to see the complete history of Richard S Levy’s form 4 insider trades.

Insider Ownership Summary of Richard S Levy

Ticker	Comapny	Transaction Date	Type of Owner
KOD	Kodiak Sciences Inc	2020-03-20	director
KNSA	Kiniksa Pharmaceuticals Ltd	2019-03-04	director
MDGL	Madrigal Pharmaceuticals Inc	2024-04-01	director
TARA	Protara Therapeutics Inc	2020-01-09	director
CNST	Constellation Pharmaceuticals Inc	2020-04-03	director
NLTX	Neoleukin Therapeutics Inc	2017-03-23	director
INCY	Incyte Corp	2016-01-06	EVP & Chief Drug Dev&Medical Of

Richard S Levy Latest Holdings Summary

Richard S Levy currently owns a total of 3 stocks. Among these stocks, Richard S Levy owns 10,298 shares of Madrigal Pharmaceuticals Inc (MDGL) as of April 1, 2024, with a value of $2 Million and a weighting of 70.56%. Richard S Levy owns 16,926 shares of Incyte Corp (INCY) as of January 6, 2016, with a value of $875,751 and a weighting of 29.32%. Richard S Levy also owns 1,000 shares of Kodiak Sciences Inc (KOD) as of March 20, 2020, with a value of $3,380 and a weighting of 0.11%.

Latest Holdings of Richard S Levy

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MDGL	Madrigal Pharmaceuticals Inc	2024-04-01	10,298	204.65	2,107,486
INCY	Incyte Corp	2016-01-06	16,926	51.74	875,751
KOD	Kodiak Sciences Inc	2020-03-20	1,000	3.38	3,380

Holding Weightings of Richard S Levy

Richard S Levy Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard S Levy has made a total of 2 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 11,000 shares on April 1, 2024, which brought Richard S Levy around $3 Million.

According to the SEC Form 4 filings, Richard S Levy has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 3,937 shares on January 6, 2016, which brought Richard S Levy around $401,023.

According to the SEC Form 4 filings, Richard S Levy has made a total of 1 transactions in Kodiak Sciences Inc (KOD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kodiak Sciences Inc is the acquisition of 1,000 shares on March 20, 2020, which cost Richard S Levy around $44,330.

Insider Trading History of Richard S Levy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard S Levy Trading Performance

GuruFocus tracks the stock performance after each of Richard S Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard S Levy is 148.59%. GuruFocus also compares Richard S Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard S Levy within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard S Levy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard S Levy

Average Return

1114.53%

Average return per transaction

Outperforming Transactions

100%

4 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	68.14	148.59	551.02	1114.53	87.74	51.59
Relative Return to S&P 500(%)	60.68	135.2	531.54	1084.21	71.21	37.95

Richard S Levy Ownership Network

Ownership Network List of Richard S Levy

No Data

Ownership Network Relation of Richard S Levy

Richard S Levy Owned Company Details

What does Kodiak Sciences Inc do?

Who are the key executives at Kodiak Sciences Inc?

Richard S Levy is the director of Kodiak Sciences Inc. Other key executives at Kodiak Sciences Inc include See Remarks Jason Ehrlich , See Remarks John A. Borgeson , and director & 10 percent owner Baker Bros. Advisors Lp .

Kodiak Sciences Inc (KOD) Insider Trades Summary

Over the past 18 months, Richard S Levy made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 4,197 shares made by John A. Borgeson , and a net sale of 3,390 shares made by Jason Ehrlich .

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,587 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,587 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kodiak Sciences Inc Insider Transactions

No Available Data

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Richard S Levy is the director of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Richard S Levy made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Madrigal Pharmaceuticals Inc do?

Who are the key executives at Madrigal Pharmaceuticals Inc?

Richard S Levy is the director of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & Chief Executive Officer Paul A Friedman , director & Chief Medical Officer & EVP R&D Rebecca Taub , and Senior VP & Chief Pharma Dev. Robert E. Waltermire .

Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary

Over the past 18 months, Richard S Levy made 2 insider transaction in Madrigal Pharmaceuticals Inc (MDGL) with a net sale of 33,489. Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .

In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Madrigal Pharmaceuticals Inc Insider Transactions

No Available Data

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Richard S Levy is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Chief Financial Officer Patrick Fabbio , 10 percent owner Opaleye Management Inc. , and director & CEO and President Jesse Shefferman .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Richard S Levy made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 15,473 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protara Therapeutics Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Richard S Levy is the director of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Richard S Levy is the director of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

Over the past 18 months, Richard S Levy made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

What does Incyte Corp do?

Who are the key executives at Incyte Corp?

Richard S Levy is the EVP & Chief Drug Dev&Medical Of of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .

Incyte Corp (INCY) Insider Trades Summary

Over the past 18 months, Richard S Levy made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Incyte Corp Insider Transactions

No Available Data

Richard S Levy Mailing Address

Above is the net worth, insider trading, and ownership report for Richard S Levy. You might contact Richard S Levy via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.

Discussions on Richard S Levy

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.